1+ hour, 45+ min ago  (124+ words) PDEU hosts Bioimpact 3. 0 The Times of India Ahmedabad: Pandit Deendayal Energy University (PDEU) in Gandhinagar hosted its flagship biotechnology symposium Bioimpact 3. 0 on Thursday and Friday with participation of industry experts, academicians, professionals and students This year's theme was "Translational Research…...

17+ hour, 10+ min ago  (255+ words) Health Sector Shifts: Cancer Deals, Supplement Sales, and Drug Approvals'Devdiscourse Health Sector Shifts: Cancer Deals, Supplement Sales, and Drug Approvals C4 Therapeutics, in collaboration with Roche, embarks on a billion-dollar cancer drug venture. Meanwhile, AG1 considers selling the company or a minority…...

8+ hour, 1+ min ago  (437+ words) No-nonsense, no-frills potato news stories from around the world by Dr Claude R. Flueckiger, Flueckiger Consulting What if the biggest innovation opportunity in agriculture is not chemistry, but biology powered by technology? The crop protection industry may be closer to that…...

5+ hour, 45+ min ago  (37+ words) Eikon Therapeutics, Inc. Statistics " BX: EIKN'Trading View Key financial stats and ratios If you want to check out the company's market capitalization, P/E Ratio, EPS, ROI, and other financial ratios, this page is your go-to hub....

3+ hour, 33+ min ago  (61+ words) Open Tools Jobs Crisis Hits the Tar Heel State Layoffs in North Carolina have surged by over 50% in 2026, with 3, 402 job cuts reported statewide. Charlotte bears the brunt, losing nearly a third of these jobs, while closures like the Family Dollar…...

22+ min ago  (468+ words) Replimune Group shares are down on Thursday. The company faces an upcoming FDA review decision on Friday, 10 April. In October 2025, the U. S. Food and Drug Administration (FDA) accepted the resubmission of the Biologics License Application (BLA) for RP1 in combination with nivolumab…...

4+ hour, 57+ min ago  (116+ words) Founded in 2004, Seeking Alpha is an industry-leading financial research platform powered by one of the world's largest investing communities. We bridge the gap between financial information and actionable insight by providing unrivaled coverage on all asset classes and access to…...

1+ day, 4+ hour ago  (317+ words) The U. S. Food and Drug Administration (FDA) on Friday concluded that Replimmune Group Inc. (NASDAQ: REPL) Biologics License Application (BLA) for vusolimogene oderparepvec in combination with nivolumab does not provide sufficient evidence of effectiveness for treating advanced melanoma. The agency issued…...

6+ hour, 42+ min ago  (23+ words) Yahoo Finance Oops, something went wrong Bio Vie CEO explains Bezisterim Parkinson's trial results - ICYMI...

2+ hour, 16+ min ago  (505+ words) Earlier this year, IGC secured funding to support the trial, which is now actively enrolling participants, including a new site in Colombia added in March. The key near-term event is the release of trial data in the first quarter of…...